Application of artificial intelligence for improving early detection and prediction of therapeutic outcomes for gastric cancer in the era of precision oncology

Z Wang, Y Liu, X Niu - Seminars in Cancer Biology, 2023 - Elsevier
Gastric cancer is a leading contributor to cancer incidence and mortality globally. Recently,
artificial intelligence approaches, particularly machine learning and deep learning, are …

Challenges and therapeutic opportunities in the dMMR/MSI-H colorectal cancer landscape

N Mulet-Margalef, J Linares, J Badia-Ramentol… - Cancers, 2023 - mdpi.com
Simple Summary Between 5% and 15% of colorectal cancers (CRC) show deficiencies in
the mismatch repair machinery and high microsatellite instability (dMMR/MSI-H). dMMR/MSI …

A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma

W Ju, R Xia, D Zhu, S Dou, G Zhu, M Dong… - Nature …, 2022 - nature.com
Novel neoadjuvant therapy regimens are warranted for oral squamous cell carcinoma
(OSCC). In this phase I trial (NCT04393506), 20 patients with locally advanced resectable …

Neutrophil extracellular traps promote angiogenesis in gastric cancer

S Yang, B Sun, J Li, N Li, A Zhang, X Zhang… - Cell Communication and …, 2023 - Springer
Although antiangiogenic therapy has been used in gastric cancer, disease progression due
to drug resistance remains common. Neutrophils play an important role in the occurrence …

Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer

J Ros, F Balconi, I Baraibar, N Saoudi Gonzalez… - Frontiers in …, 2023 - frontiersin.org
Immune checkpoint inhibitors have reshaped the prognostic of several tumor types,
including metastatic colorectal tumors with microsatellite instability (MSI). However, 90-95 …

PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer

Y Zhang, Y Yang, Y Chen, W Lin, X Chen, J Liu… - Frontiers in …, 2022 - frontiersin.org
Gastric cancer (GC) is one of the main causes of cancer incidence rate and mortality
worldwide. As the main breakthrough direction, the application of immune checkpoint …

(Im) maturity in tumor ecosystem

K Mortezaee, J Majidpoor - Frontiers in oncology, 2022 - frontiersin.org
Tumors have special features that make them distinct from their normal counterparts.
Immature cells in a tumor mass and their critical contributions to the tumorigenesis will open …

New clinical trial design in precision medicine: discovery, development and direction

XP Duan, BD Qin, XD Jiao, K Liu, Z Wang… - Signal Transduction and …, 2024 - nature.com
In the era of precision medicine, it has been increasingly recognized that individuals with a
certain disease are complex and different from each other. Due to the underestimation of the …

LRG1 mediated by ATF3 promotes growth and angiogenesis of gastric cancer by regulating the SRC/STAT3/VEGFA pathway

L He, A Feng, H Guo, H Huang, Q Deng, E Zhao… - Gastric Cancer, 2022 - Springer
Background Increasing evidence indicates that leucine-rich-alpha-2-glycoprotein 1 (LRG1)
is associated with multiple malignancies, but whether it participates in gastric cancer (GC) …

KAI1 (CD82) is a key molecule to control angiogenesis and switch angiogenic milieu to quiescent state

JW Lee, J Hur, YW Kwon, CW Chae, JI Choi… - Journal of Hematology & …, 2021 - Springer
Background Little is known about endogenous inhibitors of angiogenic growth factors. In this
study, we identified a novel endogenous anti-angiogenic factor expressed in pericytes and …